Form 8-K - Current report:
SEC Accession No. 0001193125-21-103339
Filing Date
2021-04-01
Accepted
2021-04-01 08:42:02
Documents
16
Period of Report
2021-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d142024d8k.htm   iXBRL 8-K 25281
2 EX-10.1 d142024dex101.htm EX-10.1 29674
3 EX-99.1 d142024dex991.htm EX-99.1 7141
7 GRAPHIC g142024hj02.jpg GRAPHIC 5035
8 GRAPHIC g142024snap0001.jpg GRAPHIC 5537
  Complete submission text file 0001193125-21-103339.txt   207907

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lnth-20210331.xsd EX-101.SCH 3068
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20210331_lab.xml EX-101.LAB 17372
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20210331_pre.xml EX-101.PRE 10951
9 EXTRACTED XBRL INSTANCE DOCUMENT d142024d8k_htm.xml XML 3241
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 21796156
SIC: 2835 In Vitro & In Vivo Diagnostic Substances